Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084573 | PMC |
http://dx.doi.org/10.1177/20406223231164523 | DOI Listing |
Antivir Ther
May 2022
The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Background: The World Health Organization recommends continuation with the failing second-line regimen if third-line option is not available. We investigated treatment outcomes among people living with HIV in Asia who continued with failing second-line regimens compared with those who had treatment modifications after failure.
Methods: Treatment modification was defined as a change of two antiretrovirals, a drug class change or treatment interruption (TI), all for >14 days.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!